SR

Sundaresan Rajagopalan

Active Director Additional Director DIN 02326171
DIN 02326171 First appointment Nov 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Nov 2008
Shareholding value •••• Premium profile

About Sundaresan Rajagopalan

Data last updated:

Sundaresan Rajagopalan is an Additional Director at Transe Vision Care Private Limited (since 2018), Director at Senses Pharmaceuticals Private Limited (since 2018) and Director at Quest Teleradiology Solutions Private Limited (since 2018). The companies operate in Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹60.02 Cr; the largest is Transe Vision Care Private Limited at ₹26.21 Cr (FY 2025). Earlier, Sundaresan Rajagopalan was a Whole-Time Director at Dr. Agarwal's Health Care Limited (2010–2016) and Director at Dr Agarwal's Opticals Limited (from 2008).

DIN 02326171
Primary Designation Additional Director
Industry Healthcare
First Appointment 03 Nov 2008
Oldest Company Age 17 yrs
Largest company Transe Vision Care Private Limited · ₹26.21 Cr (FY 2025)
Combined revenue ₹60.02 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Transe Vision Care Private Limited U33111KA2012PTC062691
Additional Director25 Jun 20182012₹26.21 Cr (FY 2025)Active
Director04 Apr 20182008₹26.08 Cr (FY 2025)Active
Director07 Jun 20182013₹7.73 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Agarwal's Health Care Limited L85100TN2010PLC075403
Whole-Time Director16 Aug 20102010₹2,125 Cr (FY 2026)Active
Dr Agarwal's Opticals Limited U25205TN2008PLC069737
Director03 Nov 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Senses Pharmaceuticals Private Limited
Dr Agarwal's Opticals Limited
Transe Vision Care Private Limited
Quest Teleradiology Solutions Private Limited
Premium access

Shareholding and investment profile for Sundaresan Rajagopalan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sundaresan Rajagopalan

Sundaresan Rajagopalan currently holds 3 directorships: Transe Vision Care Private Limited (Additional Director, since 25 Jun 2018, revenue ₹26.21 Cr (FY 2025)); Senses Pharmaceuticals Private Limited (Director, since 04 Apr 2018, revenue ₹26.08 Cr (FY 2025)); Quest Teleradiology Solutions Private Limited (Director, since 07 Jun 2018, revenue ₹7.73 Cr (FY 2024)).

Sundaresan Rajagopalan was first appointed on 03 Nov 2008 as Director at Dr Agarwal's Opticals Limited. The most recent appointment on record is 25 Jun 2018 at Transe Vision Care Private Limited.

The 3 current companies of Sundaresan Rajagopalan that report revenue have a combined latest revenue of ₹60.02 Cr: Transe Vision Care Private Limited ₹26.21 Cr (FY 2025); Senses Pharmaceuticals Private Limited ₹26.08 Cr (FY 2025); Quest Teleradiology Solutions Private Limited ₹7.73 Cr (FY 2024).

Sundaresan Rajagopalan held 2 earlier board appointments: Dr. Agarwal's Health Care Limited (Whole-Time Director, 16 Aug 2010 to 08 Apr 2016); Dr Agarwal's Opticals Limited (Director, from 03 Nov 2008).

The current boards of Sundaresan Rajagopalan's companies include Kapil Jhaver (Transe Vision Care Private Limited), Ramamurthy Bhuvaneswari (Transe Vision Care Private Limited), Rangarajan Vijayaragavan (Transe Vision Care Private Limited), Velayudham Suresh (Senses Pharmaceuticals Private Limited), Nirupama Karthikeyan (Quest Teleradiology Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available